BLCO — Bausch & Lomb Corp
—
NYSE ·
Unknown ·
Unknown ·
CIK 1860742 ·
Last close
$16.86
Market Cap
$6.02B
52W High
$18.92
52W Low
$13.77
ADV30
382,593
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,394,000,000 | 867,000,000 | 108,000,000 | -14,000,000 | 13,859,000,000 | 367,000,000 | 7,415,000,000 |
| Mar 2026 | 1,244,000,000 | 761,000,000 | 59,000,000 | -71,000,000 | 13,780,000,000 | 268,000,000 | 7,328,000,000 |
| Dec 2025 | 1,405,000,000 | 872,000,000 | 158,000,000 | -58,000,000 | 14,022,000,000 | 383,000,000 | 7,503,000,000 |
| Sep 2025 | 1,281,000,000 | 771,000,000 | 80,000,000 | -28,000,000 | 13,832,000,000 | 310,000,000 | 7,332,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$458,000,000
Investing CF
$-466,000,000
Financing CF
$118,000,000
CapEx
$-321,000,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.48
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,016,000,000
Inventory
$999,000,000
Receivables
$1,160,000,000
ST Investments
—
EBIT TTM
$324,000,000
Pretax Income TTM
$-65,000,000
Interest Exp TTM
$389,000,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,324,000,256
EBITDA
$816,000,000
Free Cash Flow
$323,000,000
Enterprise Value
$10,977,100,800
Total Cash
$367,000,000
Total Debt
$5,114,999,808
Shares Out
357,165,246
Trailing EPS
$-0.48
Book Value
$18.09
ROE
-2.5%
ROA
1.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,101,000,000 | 188,000,000 | -360,000,000 | 14,022,000,000 | 7,503,000,000 | 6,448,000,000 | 283,000,000 |
| Dec 2024 | 4,791,000,000 | 206,000,000 | -317,000,000 | 13,469,000,000 | 6,925,000,000 | 6,473,000,000 | 232,000,000 |
| Dec 2023 | 4,146,000,000 | 204,000,000 | -260,000,000 | 13,442,000,000 | 6,522,000,000 | 6,850,000,000 | -17,000,000 |
| Dec 2022 | 3,768,000,000 | 220,000,000 | 6,000,000 | 11,144,000,000 | 4,043,000,000 | 7,033,000,000 | 345,000,000 |
TTM Snapshot
Revenues TTM
$4,282,000,000
NetIncome TTM
$-310,000,000
OpCashFlow TTM
$0
Assets (Latest)
$14,022,000,000
Forward EPS
$1.11
Max Pain — expiry 2026-10-16
max pain strike: $17.00 · spot: $16.82 · call oi: 2,357 · put oi: 81
Expected Move to 2026-10-16:
±$1.27
(7.58%) —
implied range
$15.54 –
$18.09
· ATM straddle on $17.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CROX | Crocs, Inc. | $6.05B | $126.14 | — |
| ERELY | Eregli Demir ve Celik Fabrikalari TAS/ADR | $6.05B | $9.00 | — |
| LPGCY | Laopu Gold Co. Ltd./ADR | $6.06B | $4.22 | — |
| ST | Sensata Technologies Holding plc | $6.14B | $42.19 | — |
| SLFPY | STANDARD LIFE PLC | $5.88B | $13.13 | — |
News headlines (Yahoo Finance, 1h cache)
Robinson Pharma, Inc. Receives "Above and Beyond" Supplier Award from Bausch + Lomb for September 2026
2026-09-16 22:24 · Yahoo
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
2026-09-11 10:11 · Yahoo
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
2026-09-01 10:58 · Yahoo
Bausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers
2026-08-29 23:06 · Yahoo
3 Healthcare Stocks We Steer Clear Of
2026-08-27 14:33 · Yahoo
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q2 Earnings: Bausch + Lomb (NYSE:BLCO) Vs The Rest Of The Pack
2026-08-25 16:54 · Yahoo
Bausch + Lomb Advances Two First-in-Class Eye Health Therapies
2026-08-25 15:53 · Yahoo
Bausch + Lomb Advances Dry Eye Drug to Phase III as Pain Candidate Hits Phase Ib Goal
2026-08-25 01:01 · Yahoo
Bausch + Lomb Plans to Advance Dual-Action Eye Drop Targeting Evaporative and Inflammatory Dry Eye Disease to Phase 3
2026-08-24 21:38 · Yahoo
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
2026-08-24 20:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.